Want to see AVTR full AI Analyst Report?
AVTR Stock Chart & Stats
$11.76
$0.32(2.80%)
At close: 4:00 PM EDT
$11.76
$0.32(2.80%)
Day’s Range― - ―
52-Week Range$7.27 - $15.93
Previous CloseN/A
Volume16.50M
Average Volume (3M)8.85M
Market Cap
$9.13B
Enterprise Value$10.10K
Total Cash (Recent Filing)$306.80M
Total Debt (Recent Filing)$3.70B
Price to Earnings (P/E)―
Beta0.92
Next Earnings
Oct 23, 2026EPS Estimate
0.21Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.84
Shares Outstanding676,358,800
10 Day Avg. Volume10,970,589
30 Day Avg. Volume8,850,736
Financial Highlights & Ratios
PEG Ratio0.08
Price to Book (P/B)1.40
Price to Sales (P/S)1.19
P/FCF Ratio15.70
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$12.50Price Target Upside6.29% Upside
Rating ConsensusHold
Number of Analyst Covering14
EPS Forecast (FY)0.81
Revenue Forecast (FY)$6.59B
Bulls Say, Bears Say
Bulls Say
Recurring, Embedded Consumables DemandAvantor's core model sells high-frequency consumables, reagents and lab supplies into regulated workflows. Qualification friction and bundled services create switching costs and recurring revenue, providing a durable, predictable revenue base across biopharma, healthcare and research markets.
Positive Cash GenerationConsistent positive operating cash flow and FCF give Avantor financial flexibility to fund operations, repay debt and invest in growth programs. Even with weaker year-over-year FCF, sustained cash generation from recurring product sales supports deleveraging and strategic execution over the medium term.
Revival Program Productivity GainsMeasured throughput increases and faster onboarding from the Revival program reduce operating unit costs and shorten customer conversion time. These structural efficiency gains can lift sustainable margins and improve service, reinforcing competitive positioning and scalable commercial execution.
Bears Say
Deteriorated Profitability / Net LossesLarge net losses over 2025 and TTM 2026 materially weaken returns on capital and shareholder equity. Persistent negative profitability constrains reinvestment, raises the hurdle to restore ROIC, and increases reliance on cash generation and structural margin fixes to return to sustainable earnings.
BMP Segment Demand HeadwindsBMP is a meaningful contributor and is facing discrete order normalization and electronic materials weakness. Prolonged softness or volatility in BMP revenues creates concentration risk for consolidated growth and can pressure segment margins until demand stabilizes or product mix improves.
Leverage Remains Above Stated TargetAlthough debt has been reduced, adjusted net leverage stays above the firm's <3.0x target, keeping interest burden and covenant sensitivity elevated. Sustained deleveraging requires continued FCF and limits flexibility for large M&A or heavy reinvestment until leverage falls to target levels.
Avantor News
AVTR FAQ
What was Avantor Inc’s price range in the past 12 months?
Avantor Inc lowest stock price was $7.26 and its highest was $15.93 in the past 12 months.
What is Avantor Inc’s market cap?
Avantor Inc’s market cap is $9.13B.
When is Avantor Inc’s upcoming earnings report date?
Avantor Inc’s upcoming earnings report date is Oct 23, 2026 which is in 64 days.
How were Avantor Inc’s earnings last quarter?
Avantor Inc released its earnings results on Jul 29, 2026. The company reported $0.21 earnings per share for the quarter, beating the consensus estimate of $0.192 by $0.018.
Is Avantor Inc overvalued?
According to Wall Street analysts Avantor Inc’s price is currently Undervalued.
Does Avantor Inc pay dividends?
Avantor Inc does not currently pay dividends.
What is Avantor Inc’s EPS estimate?
Avantor Inc’s EPS estimate is 0.21.
How many shares outstanding does Avantor Inc have?
Avantor Inc has 676,358,800 shares outstanding.
What happened to Avantor Inc’s price movement after its last earnings report?
Avantor Inc reported an EPS of $0.21 in its last earnings report, beating expectations of $0.192. Following the earnings report the stock price went up 15.781%.
Which hedge fund is a major shareholder of Avantor Inc?
Currently, no hedge funds are holding shares in AVTR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Avantor Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$12.50 (6.29% Upside)
$12.50 (6.29% Upside)
Blogger Sentiment
Neutral
AVTR Sentiment 60%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 17.7M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 1.1%
Last 30 Days ▲ 3.6%
Last 30 Days ▲ 3.6%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-18.34%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-9.24%
Trailing 12-Months
Company Description
Avantor Inc
Avantor, Inc., a company established in 1904 and based in Radnor, Pennsylvania, is a global provider of vital products and specialized services. Operating across the Americas, Europe, Asia, the Middle East, and Africa, Avantor caters to a wide array of industries, including biopharmaceuticals, healthcare, educational institutions, government bodies, advanced technology firms, and applied materials enterprises. The company's extensive product portfolio features essential materials and consumables, such as high-purity chemicals and reagents, laboratory supplies, custom-formulated silicone materials, tailored excipients, single-use assemblies, process chromatography resins and columns, analytical sample preparation kits, educational and microbiology products, clinical trial kits, peristaltic pumps, and various fluid handling tips. Beyond consumables, Avantor also supplies advanced equipment and instrumentation. This range includes filtration and virus inactivation systems, incubators, analytical devices, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. Complementing its product offerings, Avantor delivers a suite of crucial services. These encompass on-site laboratory and production support, clinical services, equipment maintenance, comprehensive procurement and sourcing solutions, and specialized biopharmaceutical material scale-up and development expertise.
AVTR Company Deck
AVTR Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed tangible operational progress and improving commercial momentum, highlighted by VWR's return to organic growth, strong free cash flow generation, measurable Revival-driven productivity gains, and raised full-year guidance. These positives are balanced against near-term headwinds in the BMP segment from discrete order normalization, ongoing inflationary and FX pressures, and leverage that remains above the company's target. Management expressed confidence in accelerating growth into the second half and into 2027, supported by order momentum and execution improvements.View all AVTR earnings summariesAVTR Net sales Breakdown
58.44% Americas
34.74% Europe
6.82% AMEA
AVTR Stock 12 Month Forecast
Average Price Target
$12.50
▲(6.29% Upside)
Technical Analysis
Albemarle
―
Eastman Chemical
―
Quaker Chemical
―
Sociedad Quimica Y Minera SA
―
Westlake Corporation
―
Ownership Overview
0.64% Insiders
40.90% Mutual Funds
33.51% Other Institutional Investors
6.12% Public Companies and
Individual Investors